The Tyrosine Kinase Src Regulates Adhesion and Survival in Waldenstrom Macroglobulinemia.

被引：0

作者：

Ngo, Hai T. ^{[1
]}

Farag, Mena ^{[1
]}

Jia, Xiaoying ^{[1
]}

Burwick, Nicolas ^{[1
]}

Methem, Molly R. ^{[1
]}

Leleu, Xavier ^{[2
]}

Runnels, Judith ^{[1
]}

Azab, Abdel Kareern ^{[1
]}

Roccaro, Aldo M. ^{[1
]}

Azab, Feda ^{[1
]}

Sacco, Antonio ^{[1
]}

Quang, Phong ^{[1
]}

Tai, Yu-Tzu ^{[1
]}

Anderson, Kenneth C. ^{[1
]}

Ghobrial, Irene M. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Ctr Hosp Reg & Univ Lille, Hop Huriez, Serv Malad Sang, F-59037 Lille, France

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：906 / 906

页数：1

共 50 条

[41] Heavy chain somatic hypermutation status in Waldenstrom's macroglobulinemia.
Schop, RFJ
Tschumper, RC
Jelinek, DF
Greipp, PR
Kyle, RA
Fonseca, R
BLOOD, 2001, 98 (11) : 154A - 154A
[42] Bing-Neel syndrome in a patient with Waldenstrom's macroglobulinemia.
Pasmans, R.
Schreuder, T.
EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 558 - 558
[43] Fludarahine, mitoxantrone and dexamethasone in the treatment of refractory Waldenstrom's macroglobulinemia.
Rauch, A
Pasion, A
BLOOD, 1997, 90 (10) : 4139 - 4139
[44] Clinical Course and Prognosis of Smoldering (Asymptomatic) Waldenstrom's Macroglobulinemia.
Kyle, Robert
Benson, Joanne
Larson, Dirk
Therneau, Terry
Dispenzieri, Angela
Melton, L. Joseph, III
Rajkumar, S. Vincent
BLOOD, 2008, 112 (11) : 936 - 937
[45] Activation of NFkB is not a feature of multiple myeloma or Waldenstrom's macroglobulinemia.
Leitch, D
Barrans, SL
Jack, A
Owen, RG
BLOOD, 2002, 100 (11) : 395A - 395A
[46] Preferential inhibition of malignant cell growth by CDDO in Waldenstrom macroglobulinemia.
Elsawa, Sherine F.
Novak, Anne J.
Konopleva, Marina
Andreeff, Michael
Witzig, Thomas E.
Ansell, Stephen M.
BLOOD, 2006, 108 (11) : 715A - 715A
[47] Update of bolus administration of cladribine in the treatment of Waldenstrom's macroglobulinemia.
Hampshire, A
Saven, A
BLOOD, 2003, 102 (11) : 402A - 402A
[48] Bcl-2 antisense treatment for Waldenstrom's macroglobulinemia.
Nichols, GL
Lin, N
Sur, M
Benimetskaya, L
Stein, CA
BLOOD, 2002, 100 (11) : 579A - 579A
[49] Prognostic factors add criteria to treat Waldenstrom's macroglobulinemia.
Morel, P
Duhamel, A
Dimopoulos, M
San Miguel, J
Barlogie, B
Kyle, R
Leblond, V
Dhodapkar, M
Mc Coy, J
Treon, S
Gobbi, PG
Merlini, G
ANNALS OF ONCOLOGY, 2005, 16 : 261 - 262
[50] Hepatitis C viral infection is not associated with Waldenstrom's macroglobulinemia.
Leleu, X
O'Connor, K
Ho, A
Santos, DD
Manning, R
Xu, L
Hatjiharissi, E
Tournilhac, O
Chemaly, M
Branagan, AR
Hunter, ZR
Patterson, CJ
Anderson, KC
Treon, S
BLOOD, 2005, 106 (11) : 253B - 253B

← 1 2 3 4 5 →